Corcept Therapeutics
Yahoo Finance • 10 days ago
Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks
Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks Looking back on branded pharmaceuticals stocks' Q2 earnings, we examine this quarter's best and worst performers, including Merck (NYSE:MRK) an... Full story
Yahoo Finance • 18 days ago
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer
Corcept Therapeutics CORT announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Lifyorli (relacorilant) in combination with nab-pac... Full story
Yahoo Finance • 23 days ago
2 Healthcare Stocks to Research Further and 1 We Find Risky
2 Healthcare Stocks to Research Further and 1 We Find Risky Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as... Full story
Yahoo Finance • 29 days ago
Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT?
Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) offers broad healthcare exposure at a fraction of the cost, while First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides an aggressive, concentrated focus on biotechnology i... Full story
Yahoo Finance • last month
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index
[investor adjusting financial portfolio using digital market data, concept of asset rebalancing, investment strategy, risk management and wealth preservation] primeimages/iStock via Getty Images S&P Dow Jones Indices on Friday said it wil... Full story
Yahoo Finance • last month
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
NEW YORK, Sept. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 21, 2026, to co... Full story
Yahoo Finance • last month
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added
[Stock market data with uptrend vector] sitox Bloom Energy (BE [https://seekingalpha.com/symbol/BE]) jumped 6.2% post-market Friday after the manufacturer of solid oxide fuel cell systems for on-site power generation was added [https://ww... Full story
Yahoo Finance • last month
Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest
Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how branded pharmac... Full story
Yahoo Finance • last month
Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks
Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks Let's dig into the relative performance of Pfizer (NYSE:PFE) and its peers as we unravel the now-completed Q2 branded pharmaceuticals earnings season. Looking ahead, t... Full story
Yahoo Finance • 2 months ago
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)
Reflecting On Branded Pharmaceuticals Stocks' Q2 Earnings: Corcept (NASDAQ:CORT) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Corcept (NASDAQ:CORT) and its... Full story
Yahoo Finance • 2 months ago
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
The State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides broad exposure to the biotech industry, while the First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) offers a much more concentrated, equal-weighted alternative. Biote... Full story
Yahoo Finance • 2 months ago
Notable ETF Outflow Detected - SPSM, CORT, GKOS, EAT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 600 Small Cap ETF (Symbol: SPSM) where we have detected an approximate $125.1 million doll... Full story
Yahoo Finance • 2 months ago
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price veloci... Full story
Yahoo Finance • 2 months ago
Stocks Settle Sharply Higher as Microsoft Leads a Surge in Tech Stocks
The S&P 500 Index ($SPX) (SPY) on Thursday closed up +1.66%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +1.19%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +3.36%. September E-mini S&P futures (ESU26) rose +1.65%, and S... Full story
Yahoo Finance • 2 months ago
Stocks Rally on Stellar Microsoft Earnings and Chip Stock Strength
The S&P 500 Index ($SPX) (SPY) today is up +0.86%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +2.65%. September E-mini S&P futures (ESU26) are up +0.84%, and September E-mini... Full story
Yahoo Finance • 2 months ago
How Do the Vanguard S&P 500 Growth ETF and the State Street Small Cap Growth ETF Compare?
The choice between Vanguard S&P 500 Growth ETF (NYSEMKT:VOOG) and State Street SPDR S&P 600 Small Cap Growth ETF (NYSEMKT:SLYG) hinges on whether an investor prefers large-cap stability and tech dominance or the potential higher volatility... Full story
Yahoo Finance • 3 months ago
Corcept Therapeutics (CORT) Is Up 5.3% After Analysts Lift Full-Year Earnings Outlook Significantly
Recently, Corcept Therapeutics received an upgraded Zacks Rank of #2 (Buy) after analysts sharply raised their full-year earnings estimates, reflecting a much stronger profit outlook than previously expected. This improved earnings view ha... Full story
Yahoo Finance • 3 months ago
Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?
Investors choosing between the State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) and First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) must weigh XLV's broad healthcare diversification and low cost against FBT's conc... Full story
Yahoo Finance • 3 months ago
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know
Key Points The transaction involved 40,000 shares with an estimated value of $3.5 million on the July 15, 2026 transaction date. The activity was executed through the conversion of 40,000 options at $19.26 and $23.06 per share, which were... Full story
Yahoo Finance • 3 months ago
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound
Key Points The transaction involved the sale of 10,000 shares at $88.30 per share, resulting in a total value of $883,000 on July 15, 2026. The sale reduced the insider's total indirect equity holdings by 0.67%. These shares were held ind... Full story